TipRanks
Advertisement
Advertisement

TAK Stock Latest News

Ascentage Pharma initiated with an Outperform at William Blair
The FlyAscentage Pharma initiated with an Outperform at William Blair
5d ago
TAK
AAPG
Takeda’s ORZEYFUL launches in Japan and China
PremiumThe Fly
Takeda’s ORZEYFUL launches in Japan and China
5d ago
TAK
Takeda announces Phase 2/3 IgGNITE trial met primary endpoint
PremiumThe Fly
Takeda announces Phase 2/3 IgGNITE trial met primary endpoint
6d ago
TAK
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
PremiumCompany Announcements
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
11d ago
TAK
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
PremiumCompany Announcements
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
12d ago
TAK
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
PremiumMarket NewsAI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
13d ago
AZN
MRK
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
Premium
Company Announcements
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
15d ago
TAK
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
Premium
Company Announcements
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
19d ago
TAK
Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib
PremiumThe Fly
Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib
20d ago
TAK
Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib
PremiumThe Fly
Takeda reports new data from Phase 3 LATITUDE psoriasis studies of zasocitinib
20d ago
TAK
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
PremiumThe Fly
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
21d ago
DNA
TAK
Keros Therapeutics to receive $20M development milestone payment from Takeda
PremiumThe Fly
Keros Therapeutics to receive $20M development milestone payment from Takeda
21d ago
TAK
KROS
Innovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
PremiumThe FlyInnovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
23d ago
TAK
Takeda announces FDA acceptance of zasocitinib under priority review
Premium
The Fly
Takeda announces FDA acceptance of zasocitinib under priority review
1M ago
TAK
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
Premium
Company Announcements
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
1M ago
TAK
Takeda Advances Pediatric Bleeding Disorder Program With New Vonicog Alfa Study Update
PremiumCompany Announcements
Takeda Advances Pediatric Bleeding Disorder Program With New Vonicog Alfa Study Update
1M ago
TAK
Takeda announces publication of data from Phase 3 studies of oveporexton
PremiumThe Fly
Takeda announces publication of data from Phase 3 studies of oveporexton
1M ago
TAK
Protagonist Therapeutics announces $300M share repurchase program
PremiumThe Fly
Protagonist Therapeutics announces $300M share repurchase program
1M ago
JNJ
TAK
Keros Therapeutics announces $5M share repurchase program after Takeda payment
PremiumThe Fly
Keros Therapeutics announces $5M share repurchase program after Takeda payment
1M ago
TAK
KROS
Takeda Backs Real‑World Fruquintinib Study in Metastatic Colorectal Cancer
PremiumCompany AnnouncementsTakeda Backs Real‑World Fruquintinib Study in Metastatic Colorectal Cancer
2M ago
TAK
Takeda’s Replagal Trial in India: Fresh Clinical Update With Rare Disease Upside
Premium
Company Announcements
Takeda’s Replagal Trial in India: Fresh Clinical Update With Rare Disease Upside
2M ago
TAK
Trump Trade: President warns communities against rejecting data centers
Premium
The Fly
Trump Trade: President warns communities against rejecting data centers
2M ago
AZN
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >